Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Liposome Res ; 24(4): 290-6, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24766639

RESUMO

Capsaicin (CP), a recent FDA-approved drug for the topical treatment of neuropathic pain, is associated with several side effects like irritation, burning sensation, and erythema, resulting in poor patient compliance. The present study is an attempt to study the effect of CP encasement in nano-lipoidal carriers (NLCs) on skin-transport characteristics, in vivo pharmacological performance, skin compliance, and stability of the finished product. The study also compares two methods of NLC preparation, namely microemulsification and rotary-evaporation for various attributes. The results demonstrated that microemulsion technique produced smaller nanoparticles vis-à-vis the rotary-evaporation method. Out of the various studied solid lipids, NLCs from stearic acid offered smallest size and the highest negative zeta potential. The NLC-gel offered higher skin permeation and skin retention of CP across LACA mice skin as compared with the conventional cream. The analgesic effect was observed to be enhanced substantially than that of the conventional cream when tested on a radiant mouse tail-flick model. The most alarming problems of skin-irritation and redness were successfully taken care by NLC-gel while the mice group receiving conventional cream showed marked changes in the skin histopathology. Besides the enhanced efficacy and decreased skin-irritation, the developed CP-NLCs also found to be stable and rheologically accepted formulation for the treatment of pain-associated disorders.


Assuntos
Analgésicos não Narcóticos/administração & dosagem , Capsaicina/administração & dosagem , Portadores de Fármacos/administração & dosagem , Nanoestruturas/química , Administração Cutânea , Analgésicos não Narcóticos/efeitos adversos , Analgésicos não Narcóticos/metabolismo , Analgésicos não Narcóticos/uso terapêutico , Animais , Capsaicina/efeitos adversos , Capsaicina/metabolismo , Capsaicina/uso terapêutico , Coloides , Portadores de Fármacos/efeitos adversos , Portadores de Fármacos/metabolismo , Portadores de Fármacos/uso terapêutico , Composição de Medicamentos , Feminino , Técnicas In Vitro , Lipossomos , Camundongos , Pele/efeitos dos fármacos , Pele/metabolismo , Absorção Cutânea
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa